Here are relevant reports on : clinical-trial-logistics-market
-
Endocrine Testing Market by Type (Thyroid, Insulin, HCG, Prolactin, Progesterone, LH, FSH), Technology (Immunoassay, Tandem Mass Spectroscopy, Clinical Chemistry), End User (Hospitals, Clinical Laboratories) - Global Forecast to 2027
The global Endocrine Testing Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the increasing prevalence of the endocrine disorders such as thyroid imbalance, diabetes, Polycystic Ovary Syndrome, etc. Also, the increasing government funding and rising awareness for the endocrine hormone tests for the diagnosis and management of the endocrine disorder have also fueled the growth of the market.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020
Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million in 2020 at a CAGR of 3.5% from 2015-2020.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
Asia Pacific Healthcare IT Market by Solution [Clinical (EHR, PACs & VNA, Telehealth, CDSS, Medical Image), Nonclinical (Clinical Analytics, RCM, Interoperability), Service (Claim, Billing)], End User [Hospital, ASC, Pharmacy, Payer]-Forecast to 2030
The Asia Pacific Healthcare IT market, valued at USD 68.96 billion in 2024, stood at USD 80.69 billion in 2025 and is projected to advance at a resilient CAGR of 17.6% from 2025 to 2030, culminating in a forecasted valuation of USD 181.30 billion by the end of the period. The Asia Pacific healthcare IT market is growing steadily, driven by increasing healthcare digitalization, rising patient volumes, government initiatives to adopt health IT, and expanding use of cloud, AI, and analytics in the region.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Coagulation Analyzer Market by Product (Clinical Laboratory Analyzers, Consumables, Reagents, Systems), Test (PT Test, APT Test, D-Dimer Test), Technology (Optical, Mechanical), End User (Hospitals, Clinical Laboratory) & Region - Global Forecast to 2030
Global coagulation analyzers market valued at $3516.0M in 2024, reached $3,770.9M in 2025, and is projected to grow at a robust 7.2% CAGR, hitting $5,335.9M by 2030. The market is experiencing steady growth, primarily driven by the increasing prevalence of blood clotting disorders such as hemophilia and deep vein thrombosis. As the global population ages and chronic illnesses become more common, the demand for quick and accurate diagnostic tools continues to rise.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Predictive Clinical Biomarkers Market by Product & Service (Consumable, Software), Technology (NGS, PCR), Disease (Cancer, Infectious), Application (Clinical Diagnostics)-Forecast to 2030
The predictive clinical biomarkers market, valued at US$7.84 billion in 2024, stood at US$8.49 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2025 to 2030, culminating in a forecasted valuation of US$14.69 billion by the end of the period. he market for predictive clinical biomarkers is growing rapidly as the healthcare industry shifts toward personalized and predictive medicine.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Europe Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Molecular Diagnostics), Application (Clinical Pathology, Virology, Hematology), Animal (Dogs, Cats), End User - Forecast to 2031
The Europe companion animal diagnostics market, valued at USD0.43 billion in 2025, stood at USD0.46 billion in 2026 and is projected to advance at a resilient CAGR of 8.6% from 2026 to 2031, culminating in a forecasted valuation of USD0.70 billion by the end of the period. The market for diagnostics of companion animals in Europe is experiencing fast growth owing to factors such as increased pet ownership, animal health awareness, and advanced veterinary care being more widely accepted and costly.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
World Healthcare IT (Provider and Payor) Market - Clinical (EMR, PACS, RIS, CPOE, LIS) & Non-Clinical (RCM, Billing, Claims) Information systems Trends, opportunities & Forecast till 2015
The world healthcare IT market is expected to grow from $99.6 billion in 2010 to $162.2 billion in 2015, at a CAGR of 10.2% from 2010 to 2015. Need to cut healthcare costs, enhance clinical/administrative workflow of hospitals, and huge demand for faster, error-free, efficient healthcare delivery, is fueling the healthcare provider IT market worldwide. Furthermore, the initiatives taken by the government for adoption of healthcare IT systems globally are also a significant driving force. Some of the major initiatives expected to hugely impact the market are the U.S Healthcare reforms and ARRA incentives.
- Published: August 2011
- Price: $ 4950
- TOC Available:
-
Electronic Clinical Outcome Assessment (eCOA) Solutions Market by Modality (Wearable, Mobile, BYOD), Type (PRO, CLINRO, OBSRO, PERFO), Application (Clinical Trial (Onco, Rare, Mental Health), RWE, Registery), End User (Govt, Med Device, Pharma) - Global Forecast to 2030
The global electronic clinical outcome assessment (eCOA) solutions market, valued at US$1.94B in 2024, is forecasted to grow at a 16.1% CAGR, reaching US$2.27B by 2025 and US$4.78B by 2030. This growth is primarily driven by increasing investments in research and development from medical device companies looking for digital endpoints.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Clinical Information systems (CIS) Market (2011-2016)
Clinical information systems include software solutions that enable efficient clinical workflow. Clinical systems include EMR, computerized physician order entry, laboratory information systems, pharmacy information systems, radiology information systems, and PACS. The clinical information systems market in developed countries is growing with higher CAGR, however emerging markets are currently very nascent. Presently, clinical information systems dominate the HIS market due to their high price and rising adoption. Budgetary constraints due to low awareness levels are however restraining market growth. The global clinical information systems market is expected to grow from $1.2 billion in 2009 to $2.8 billion in 2015, at an estimated CAGR of 14.8% from 2010 to 2015.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Non Clinical Information Systems Market (2011-2016)
Non-clinical healthcare systems (NCHS) facilitate revenue cycle management and also offer automatic patient billing, cost accounting, payroll, and claims management. These functions gain high significance in light of the reported fact that improper revenue cycle management in hospitals causes a 3% to 5% loss of net revenue. For a 250-bed hospital, this figure means an annual loss of $3.5 million to $7.5 million. Improved r e lat ion with payors and patients are improved revenue cycle management are driving this market. The administrative/non-clinical systems market revenue was $12.5 billion globally in 2010. The Non Clinical Information Systems Market is estimated to reach $20.9 billion in 2015 growing at a CAGR of 10.8%.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
